Journals retract two articles with similar text regarding coronary artery disease in China
Two journals—DNA and Cell Biology and Genetic Testing and Molecular Biomarkers—have retracted two papers that concluded a polymorphism could signal a risk factor for coronary artery disease among Chinese patients, Retraction Watch reports.
The website also reports that a third paper, which was published in Molecular Biology Reports, contained similar text to the other two papers. For more, check out the link below:
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.